Today’s top gainers include the company Illumina Inc. (NASDAQ:ILMN) which is in the industry Biotechnology, gaining 2.83% today. In the last week its performance is 4.48%, and -4.83% for the past quarter. Currently, Illumina Inc., ILMN has a target price of 144.8, so today’s gain of 2.83% is a significant step towards its target price. The GAP today is therefore 1.36%.
Illumina Inc. (NASDAQ:ILMN), has a market cap of 21161.46, and is based in USA. Insider ownership is at 0.60%, and institutional ownership is 97.60%.
At the current price of 145.22, it has a dividend yield of *TBA, and its target price is 144.8. This is with a profit margin of 18.70%, and total debt/equity of 0.5. Illumina Inc. (NASDAQ:ILMN) has a P/E of 49.92, as well as a forward P/E of 37.27.
With a current EPS of 2.91, and a forecasted EPS growth for next year at 15.20%,Illumina Inc. (NASDAQ:ILMN) has had a EPS growth for the past five years at 28.90%. For the next five years EPS growth is projected to be 14.62%.
Performance for the year is -1.53%. Since its IPO date on 7/28/2000, the total performance to date is -24.34%.
Volume today for Illumina Inc. (NASDAQ:ILMN), is 2514600, while its average volume is 1265.65. Whilst the total gain today was 2.83%, it did have a day high of -22.29%.
Volatility for this week has been at 3.29%, and 2.58% for the month. The 52-week low for Illumina Inc., ILMN has been 14.26%, while the 52-week-high has reached -26.09%.
Looking at its return of investments, which is 16.60%, and its return on assets is 11.40%. Illumina Inc. (NASDAQ:ILMN) has an operating margin of 24.60%. With a sales growth of 11.30% quarter over quarter. Bearing in mind that Illumina Inc., ILMN is in the sector Healthcare, its long-term debt/equity is 0.5, and has a current ratio of 3.7 and 3.1 for quick ratio.
So what is the value of Illumina Inc.? Well its PEG is 3.42, and the P/S is 9.15, along with a P/B of 10.37. Meanwhile it has a p/cash of 14.85.